These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26707863)

  • 1. Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts.
    Kennedy JL; Xiong N; Yu J; Zai CC; Pouget JG; Li J; Liu K; Qing H; Wang T; Martin E; Levy DL; Lin Z
    Schizophr Bull; 2016 May; 42(3):772-81. PubMed ID: 26707863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
    Klejbor I; Myers JM; Hausknecht K; Corso TD; Gambino AS; Morys J; Maher PA; Hard R; Richards J; Stachowiak EK; Stachowiak MK
    J Neurochem; 2006 Jun; 97(5):1243-58. PubMed ID: 16524369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-acting elements responsible for dopaminergic neuron-specific expression of zebrafish slc6a3 (dopamine transporter) in vivo are located remote from the transcriptional start site.
    Bai Q; Burton EA
    Neuroscience; 2009 Dec; 164(3):1138-51. PubMed ID: 19755139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
    Reyes S; Cottam V; Kirik D; Double KL; Halliday GM
    Mov Disord; 2013 Sep; 28(10):1351-9. PubMed ID: 23674405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
    Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F
    Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the SLC6A3 A1343G polymorphism and schizophrenia.
    Cordeiro Q; Siqueira-Roberto J; Vallada H
    Arq Neuropsiquiatr; 2010 Oct; 68(5):716-9. PubMed ID: 21049181
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Liu K; Yu J; Zhao J; Zhou Y; Xiong N; Xu J; Wang T; Bell RL; Qing H; Lin Z
    Mol Neurobiol; 2018 Jul; 55(7):5611-5622. PubMed ID: 28983843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
    Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
    Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dopamine transporter transgenic mouse line for identification and purification of midbrain dopaminergic neurons reveals midbrain heterogeneity.
    Apuschkin M; Stilling S; Rahbek-Clemmensen T; Sørensen G; Fortin G; Herborg Hansen F; Eriksen J; Trudeau LE; Egerod K; Gether U; Rickhag M
    Eur J Neurosci; 2015 Oct; 42(7):2438-54. PubMed ID: 26286107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.
    Krabbe S; Duda J; Schiemann J; Poetschke C; Schneider G; Kandel ER; Liss B; Roeper J; Simpson EH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1498-506. PubMed ID: 25675529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
    Vuillermot S; Feldon J; Meyer U
    Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat.
    Rodríguez VM; Limón-Pacheco JH; Mendoza-Trejo MS; González-Gallardo A; Hernández-Plata I; Giordano M
    Neurotoxicology; 2013 Jan; 34():82-94. PubMed ID: 23123945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons.
    Yee AG; Lee SM; Hunter MR; Glass M; Freestone PS; Lipski J
    Neurotoxicology; 2014 Dec; 45():1-11. PubMed ID: 25193392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-mapping reveals novel alternative splicing of the dopamine transporter.
    Talkowski ME; McCann KL; Chen M; McClain L; Bamne M; Wood J; Chowdari KV; Watson A; Prasad KM; Kirov G; Georgieva L; Toncheva D; Mansour H; Lewis DA; Owen M; O'Donovan M; Papasaikas P; Sullivan P; Ruderfer D; Yao JK; Leonard S; Thomas P; Miyajima F; Quinn J; Lopez AJ; Nimgaonkar VL
    Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1434-47. PubMed ID: 20957647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disorders.
    Hoeffding LK; Duong LT; Ingason A; Rosengren A; Sorbanski E; Witt SH; Djurovic S; Andreassen OA; Hansen T; Werge T; Rasmussen HB
    Nord J Psychiatry; 2016; 70(4):276-9. PubMed ID: 26559242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia.
    Xu FL; Ding M; Wu X; Liu YP; Xia X; Yao J; Wang BJ
    J Mol Neurosci; 2020 Feb; 70(2):155-166. PubMed ID: 31440993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
    Lipska BK; Mitkus S; Caruso M; Hyde TM; Chen J; Vakkalanka R; Straub RE; Weinberger DR; Kleinman JE
    Hum Mol Genet; 2006 Sep; 15(18):2804-12. PubMed ID: 16905560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.